Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Obesity

Thanks to Wall Street, Novo Nordisk Stock is Now a Buy

Novo Nordisk has lost about a quarter of its value since the end of June. Meanwhile, indications are that its diabetes and weight-loss drugs may be useful in fighting cardiovascular disease, arthritis, opioid and alcohol addiction, and Alzheimer's. Novo remains a leader in the sector, and is trading at a…

Barchart

Weight loss drugs may cause addiction switching, says award-winning therapist

Labour’s plans to give weight loss drugs to the unemployed may not just fail: it could backfire, therapist Sally Baker explains

Evening Standard

JD Vance Suggests Democrats Want Americans To Be Unhealthy For Liberalism

Republican VP candidate JD Vance's comments on health, obesity, and political ideologies spark debate and highlight the need for evidence-based discussions.

Top News

From analysis to the latest developments in health,
read the most diverse news in one place.

Up 285% YTD, Is It Too Late to Buy This Biotech Stock?

Viking Therapeutics is making notable advancements in obesity treatment with VK2735 and exploring strategic partnerships for its NASH program, positioning itself at the forefront of metabolic and endocrine disorder therapies

Barchart

Amgen 'Laser-Focused' On Its Weight-Loss Shot As New Rival Pfizer Follows, Says CFO

Amgen is focusing deeply on its efforts to treat obesity, the CFO said Wednesday. Amgen stock rose early Thursday.

Investors Business Daily

Five reasons weight-loss jabs alone won’t help get people back to work

Prime Minister Keir Starmer and health secretary Wes Streeting have recently discussed plans to trial weight-loss injections for around 250,000 people with obesity who are unemployed in a bid to get them back into work, ease pressure on the NHS and boost the economy.

The Conversation

Pfizer Unveils Its Next Black Box In Obesity. It's Taking On Amgen.

Pfizer is taking on Amgen with its next steps in weight loss, the pharma titan said Tuesday as Pfizer stock dipped despite its beat.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Ozempic, Wegovy or Mounjaro: the battle of the weight-loss injections

As weight-loss injections emerge as key players in the government’s anti-obesity strategy, Emma Loffhagen goes inside the battle between the pharmaceutical giants providing them — and delves into what exactly sets their products apart

Evening Standard

New blood test could identify children at risk of diabetes, liver ills

Scientists have developed a novel blood test that uses lipids to identify children who are more susceptible to obesity-related problems like diabetes. Read further on Dynamite News:

Dynamite News

GLP-1 Drugs For Obesity Treatment Reduce Bariatric Surgeries By 25%: Study

The study noted that a vast majority of obese patients, strikingly 94.7%, received neither form of treatment, while 5% received GLP-1 RAs and 0.3% received surgery.

Medical Daily

Force food firms to disclose products’ health ratings, industry boss urges

Exclusive: Stéfan Descheemaeker of Nomad Foods says mandatory rules could help kickstart ‘nutrition arms race’

The Guardian - UK

Viking Therapeutics Skyrockets After Dealing A Blow To Eli Lilly's Obesity Triplet

Viking Therapeutics stock ramped higher Thursday after the company outlined its weight-loss quad — a blow to Eli Lilly's experimental triple.

Investors Business Daily

Doctors urged to look out for weight loss jab ‘misuse’

The medicines regulator has also urged medics to warn patients of side effects.

Evening Standard

Fine businesses not following anti-obesity rules on healthy food, peers say

The proposals came from the Lords’ Food, Diet and Obesity Committee.

Evening Standard

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

Is Eli Lilly Still a Top Healthcare Stock After Its Blockbuster Drug Approval?

Pharmaceutical giant Eli Lilly and Company (LLY) is on an impressive run after winning Food and Drug Administration approval for a new eczema drug called Ebglyss. As the company expands its reach in the diabetes, obesity, and eczema markets, is it a must-have in your healthcare portfolio? Read on to…

Medical Daily

History Of Eating Disorders, Pre-Pregnancy Obesity Raises Offspring's Risk Of Mental Health Diagnosis

The study found associations between a mother's history of eating disorders and pre-pregnancy body mass index (BMI) higher than the normal weight range to most of the nine psychiatric diagnoses examined in the offspring.

AAP

Reducing child, teen obesity can save $7b health costs

Reducing the rate of overweight and obesity in Australian kids and teenagers by five per cent could save them more than $7 billion in lifelong health costs.

The National (Scotland)

Labour push SNP to give Scots weight-loss jabs on NHS

LABOUR are urging the SNP to mimic their plans to tackle obesity with weight-loss jabs.

Get all your
news in one place.

100’s of premium titles.
One news app.

Top News

Mexico Implements Ban On Junk Food In Schools

Mexico's new regulations ban junk food in schools to combat childhood obesity, facing challenges in enforcement and infrastructure.

The Guardian - UK

Wes Streeting denies ‘dystopian future’ over weight-loss jabs for unemployed

UK health secretary says people will not be ‘involuntarily jabbed’ but that medications could be ‘gamechanging’

The Guardian - UK

From fashion to the food industry: 11 ways that weight-loss drugs have changed the world

The growing – and sometimes secret – use of drugs containing semaglutide has had a huge impact on how we live … but where will it end?

The Guardian - UK

Pumping the unemployed with weight-loss drugs echoes Victorian attitudes to the poor

Shifting blame to the victims of economic policy is an old trick by politicians. Now they’re using obesity to tackle joblessness

The National (Scotland)

Experts weigh in on Labour plan to offer weight loss jabs to unemployed

LABOUR plans to give obese and unemployed people weight-loss jabs as part of a drive to get them back into work and reduce pressure on the NHS…

The Guardian - UK

Weight loss jabs not ‘quick fix’ for UK worklessness, health experts warn

Scientists say using the drugs to get people back into work could carry logistical and ethical problems

The Guardian - US

Weight-loss drugs could be key reason why US obesity rates falling, experts say

Medications like Ozempic ‘transformed’ diabetes care because they improved health outcomes, say experts

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Food and Drug Administration

135 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.